The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

By sjmartinez • January 19, 2025

Packard RRS. The clinical promise of ¹⁸F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease. Nat Cardiovasc Res. 2025 Jan;4(1):1-4. doi: 10.1038/s44161-024-00587-w. PMID: 39825085.

Tags: Cardiology/Epi, Publications

Clinical outcomes among individuals with systemic inflammation following myocardial infarction: Insights from the veterans affairs healthcare system

Sandhu AT, Furst A, Rodriguez F, Kalwani N, Maron DJ, Nallamshetty S, Din N, Fan M, Khachatourian K, Skaar JR, Tonnu-Mihara I. Clinical outcomes among[...]

Age and sex specific coronary plaque characteristics among South Asians: Insights from the DILWALE CTA study

Satish P, Vajramani A, Gupta S, Ma TW, Prasad T, Lakshmanan S, Budoff M, Kalra DK, Khan MS, Leipsic J, Alsaid A, Kulkarni A. Age[...]

Comparing incidence of heart failure in individuals with enlarged cardiac chambers versus diabetes

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]